Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy | Original-Research: CLINUVEL Pharmaceuticals Limited - from Parmantier & Cie. GmbH
30.09.2025 / 10:52 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The... ► Artikel lesen |
Clinuvel Pharmaceuticals Limited: CLINUVEL to advance novel pharmaceutical formulations in preclinical program | Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug delivery platforms for peptides, melanocortinsaim to predict drug release... ► Artikel lesen |
Dividendenbekanntmachungen (04.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADMIRAL GROUP PLC GB00B02J6398 1,15 GBP 1,3255 EUR AEGON LTD ADR US0076CA1045 0,2206 USD 0,1891 EUR AMCOR PLC CDIS AU000000AMC4 0... ► Artikel lesen |
Auxly Cannabis Group Inc.: Auxly Reports Second Quarter 2025 Results | TORONTO, Aug. 14, 2025 /PRNewswire/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") a leading consumer packaged goods company... ► Artikel lesen |
Auxly Cannabis Group Inc.: Auxly Announces Results of Annual General Meeting of Shareholders | TORONTO, July 2, 2025 /CNW/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") announced today the voting results from its annual... ► Artikel lesen |
Auxly Cannabis Group Inc.: Auxly Reports 2025 First Quarter Results | TORONTO, May 15, 2025 /PRNewswire/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") a leading consumer packaged goods company... ► Artikel lesen |